Found: 47
Select item for more details and to access through your institution.
Imaging synaptic density in the living human brain.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 348, p. 1, doi. 10.1126/scitranslmed.aaf6667
- By:
- Publication type:
- Article
Validation of a simplified tissue‐to‐reference ratio measurement using SUVR for the assessment of synaptic density alterations in Alzheimer's disease using [<sup>11</sup>C]UCB‐J PET: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045928
- By:
- Publication type:
- Article
Association between cerebrospinal fluid biomarkers of neurodegeneration and PET measurements of synaptic density in Alzheimer's disease: Neuroimaging / multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044211
- By:
- Publication type:
- Article
Association between cerebral amyloid accumulation and synaptic density in Alzheimer's disease: A multitracer PET study: Neuroimaging: Imaging the human synapse in AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043631
- By:
- Publication type:
- Article
11C‐PBR28 brain PET imaging with lipopolysaccharide challenge for the study of microglia function in Alzheimer's disease: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043584
- By:
- Publication type:
- Article
In vivo measurement of widespread synaptic loss and associated tau accumulation in early Alzheimer's disease: Molecular imaging of novel biomarkers for neurodegeneration and ADRD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037791
- By:
- Publication type:
- Article
PBR28 Brain PET imaging with lipopolysaccharide challenge for the study of microglia function in Alzheimer's disease: Molecular imaging of novel biomarkers for neurodegeneration and ADRD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037792
- By:
- Publication type:
- Article
In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 7, p. 974, doi. 10.1002/alz.12097
- By:
- Publication type:
- Article
P4‐481: ASSOCIATION BETWEEN ENTORHINAL CORTICAL TAU ACCUMULATION AND HIPPOCAMPAL SYNAPTIC DENSITY IN OLDER INDIVIDUALS WITH NORMAL COGNITION AND EARLY ALZHEIMER'S DISEASE: PRELIMINARY EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1497, doi. 10.1016/j.jalz.2019.08.027
- By:
- Publication type:
- Article
P2‐349: ASSOCIATION BETWEEN MGLUR5 AND SYNAPTIC DENSITY: A MULTI‐TRACER STUDY OF HEALTHY AGING AND ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P729, doi. 10.1016/j.jalz.2019.06.2756
- By:
- Publication type:
- Article
IC‐P‐140: ASSOCIATION BETWEEN MGLUR5 AND SYNAPTIC DENSITY: A MULTI‐TRACER STUDY IN HEALTHY AGING AND ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P115, doi. 10.1016/j.jalz.2019.06.4254
- By:
- Publication type:
- Article
IC‐P‐140: ASSOCIATION BETWEEN MGLUR5 AND SYNAPTIC DENSITY: A MULTI‐TRACER STUDY IN HEALTHY AGING AND ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P115, doi. 10.1016/j.jalz.2019.06.4254
- By:
- Publication type:
- Article
P2‐365: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P832, doi. 10.1016/j.jalz.2018.06.1056
- By:
- Publication type:
- Article
P1‐469: PET IMAGING OF METABOTROPIC GLUTAMATE RECEPTOR 5 BINDING IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P501, doi. 10.1016/j.jalz.2018.06.479
- By:
- Publication type:
- Article
IC‐P‐183: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P152, doi. 10.1016/j.jalz.2018.06.2250
- By:
- Publication type:
- Article
IC‐04‐03: PET IMAGING OF METABOTROPIC GLUTAMATE RECEPTOR 5 BINDING IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P8, doi. 10.1016/j.jalz.2018.06.2051
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Simplified Quantification of <sup>11</sup>C-UCB-J PET Evaluated in a Large Human Cohort.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.243949
- By:
- Publication type:
- Article
Simplified Quantification of <sup>11</sup>C-UCB-J PET Evaluated in a Large Human Cohort.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.243949
- By:
- Publication type:
- Article
Simplified Quantification of <sup>11</sup>C-UCB-J PET Evaluated in a Large Human Cohort.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.243949
- By:
- Publication type:
- Article
Simplified Quantification of<sup>11</sup>C-UCB-J PET Evaluated in a Large Human Cohort.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.243949
- By:
- Publication type:
- Article
Evaluation of <sup>11</sup>C-LSN3172176 as a novel PET tracer for imaging M<sub>1</sub> muscarinic acetylcholine receptors in non-human primates.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.222034
- By:
- Publication type:
- Article
Evaluation of <sup>11</sup>C-LSN3172176 as a Novel PET Tracer for Imaging M<sub>1</sub> Muscarinic Acetylcholine Receptors in Nonhuman Primates.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 8, p. 1147, doi. 10.2967/jnumed.118.222034
- By:
- Publication type:
- Article
Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand <sup>11</sup>C-BMT-136088 for Lung Imaging in Rhesus Monkeys.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 2, p. 327, doi. 10.2967/jnumed.117.195073
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>11</sup>C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 777, doi. 10.2967/jnumed.115.168179
- By:
- Publication type:
- Article
The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [<sup>11</sup>C]UCB-J.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 1012, doi. 10.1007/s00259-023-06487-8
- By:
- Publication type:
- Article
Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory <sup>11</sup>C‐UCB‐J positron emission tomography study in humans.
- Published in:
- Addiction Biology, 2022, v. 27, n. 2, p. 1, doi. 10.1111/adb.13123
- By:
- Publication type:
- Article
Comparison of [ 11 C]UCB-J and [ 18 F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 9, p. 2395, doi. 10.1177/0271678X211004312
- By:
- Publication type:
- Article
First in-human PET study and kinetic evaluation of [ 18 F]AS2471907 for imaging 11β-hydroxysteroid dehydrogenase type 1.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2020, v. 40, n. 4, p. 695, doi. 10.1177/0271678X19838633
- By:
- Publication type:
- Article
Kinetic evaluation and test–retest reproducibility of [<sup>11</sup>C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2018, v. 38, n. 11, p. 2041, doi. 10.1177/0271678X17724947
- By:
- Publication type:
- Article
Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [11C]UCB-J.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-020-00742-y
- By:
- Publication type:
- Article
PET imaging of mGluR5 in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-0582-0
- By:
- Publication type:
- Article
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [<sup>11</sup>C]UCB‐J positron emission tomography study.
- Published in:
- Epilepsia (Series 4), 2020, v. 61, n. 10, p. 2183, doi. 10.1111/epi.16653
- By:
- Publication type:
- Article
A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.
- Published in:
- Epilepsia (Series 4), 2019, v. 60, n. 5, p. 958, doi. 10.1111/epi.14701
- By:
- Publication type:
- Article
Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [<sup>18</sup>F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 10, p. 1215, doi. 10.1001/jamaneurol.2018.1836
- By:
- Publication type:
- Article
Drug characteristics derived from kinetic modeling: combined <sup>11</sup>C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00944-5
- By:
- Publication type:
- Article
IC‐04‐03: PET IMAGING OF METABOTROPIC GLUTAMATE RECEPTOR 5 BINDING IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P8, doi. 10.1016/j.jalz.2018.06.2051
- By:
- Publication type:
- Article
Assessment of gray matter microstructure and synaptic density in Alzheimer's Disease: a multimodal imaging study with DWI and SV2A PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065064
- By:
- Publication type:
- Article
Association of synaptic density and glucose metabolism with cognitive performance in early Alzheimer's disease: a PET imaging study with [11C]UCB‐J and [18F]FDG.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.062595
- By:
- Publication type:
- Article
Assessment of gray matter microstructure and synaptic density in Alzheimer's Disease: a multimodal imaging study with DWI and SV2A PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.065162
- By:
- Publication type:
- Article
Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [<sup>11</sup>C]UCB‐J.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 12, p. 2527, doi. 10.1002/alz.12582
- By:
- Publication type:
- Article
Synaptic density is associated with cognitive performance in Alzheimer’s disease: A PET imaging study with [11C]UCB‐J.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054213
- By:
- Publication type:
- Article
Cerebrospinal fluid and brain PET measures of synaptic density glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054831
- By:
- Publication type:
- Article